Biochemistry Flashcards
What gives DNA its (-) charge?
Phosphate groups
What gives histones their (+) charge?
Lysine and Arginine (what the octamer subunits primarily consist of)
What histones make up the nucleosome core in the “bead” on a string of chromatin? What histone ties the nucleosome “beads” together in a string?
Nucleosome core histones: H2A, H2B, H3, H4
H1 is the only histone that’s not in the nucleosome core; it ties the nucleosome core/beads together in a “string”
*referring to chromatin here (chromatin is the condensed form of DNA that allows it to fit into the nucleus)
Heterochromatin vs Euchromatin
Heterochromatin: highly condensed, transcriptionally inactive, sterically inaccessible
Euchromatin: less condensed, transcriptionally active, sterically accessible
How to mismatch repair enzymes distinguish between old and new strands?
Because template strand cytosine and adenine are methylated in DNA replication; this allows mismatch repair enzymes distinguish between old and new strands
What does hypermethylation do to DNA transcription?
inactivates transcription of DNA (“methylation makes DNA mute”)
What does histone acetylation do?
Relaxes DNA coiling, allowing for transcripiton (“acetylation makes DNA active”)
List the Purines. How many rings?
PURe As Gold: Adenine and Guanine
Have 2 rings
List the Pyrimidines. How many rings?
CUT the PY: Cytosine, Uracil, Thymine
Have 1 ring
RNA vs DNA nucleotides?
Uracil in RNA
Thymine in DNA
Which nucleotide has a ketone?
Which has a methyl?
Which makes uracil when deaminated?
Guanine has a ketone
Thymine has a methyl
Deamination of cytosine makes uracil
G-C vs A-T bonds:
G-C –> have 3 H-bonds, stronger than A-T bonds, which have 2 H-bonds
the more G-C content, the higher the melting point
Nucleoside vs Nucleotide
Nucleoside = base + ribose (sugar) Nucleotide = base + ribose + phosphate; linked by 3'-5' phosphodiester bond
Which amino acids are necessary for purine synthesis?
Glycine
Aspartate
Glutamine
Ribonucleotide Reductase
Convert ribonucleotides to deoxyribonucleotides in de novo pyrimidine synthesis (UDP –> dUDP)
Purine synthesis
1) Start with sugar + phosphate (PRPP)
2) Add base
Pyrimidine synthesis
1) Make temporary base (orotic acid)
2) Add sugar + phosphate (PRPP)
3) Modify base
Rate limiting enzyme in Purine synthesis?
Glutamine-PRPP-Amidotransferase (catalyzes step from PRPP –> –> –> IMP)
Rate limiting enzyme in Pyrimidine synthesis?
CPS - 2 = carbamoyl phosphate synthetase 2 (catalyzes step from ATP + CO2 + Glutamine –> Carbamoyl Phosphate)
Hydroxyurea mechanism
anti-cancer drug; inhibits ribonucleotide reductase (UDP–>dUDP)
6-mercaptopurine mechanism
blocks de-novo purine synthesis by blocking PRPP synthetase (Ribose-5-P –> PRPP)
5-Fluorouracil mechanism
Inhibits thymidylate synthase (dUMP –> dTMP)
get decreased dTMP
Methotrexate mechanism
inhibits dihydrofolate reductase (DHF–>THF); [thymidylate synthase uses THF (tetrahydrofolate), the active form of folic acid, to convert dUMP–>dTMP]
(get decreased dTMP)
Trimethoprim mechanism
inhibits bacterial dihydrofolate reductase (get decreased dTMP)
Mycophenylate mechanism
inhibits IMP (inosine monophosphate) dehydrogenase (IMP–>GMP)
How would a folic acid deficiency affect pyrimidine synthesis?
Thymidylate synthase (converts dUMP –> dTMP) uses THF, which is the active form of folic acid. So, without it, get decreased dTMP.
increased orotic acid in urine, megaloblastic anemia (that does not improve with vitamin B12 or folic acid), FTT; no hyperammonemia
Orotic aciduria (inability to convert orotic acid to UMP in the de novo pyrimidine synthesis pathway; d/t defect in either orotic acid phosphoribosyltransferase or orotidine-5’-phosphate decarboxylase)
- Autosomal recessive
- treat with oral uridine administration
What is the cause of orotic aciduria?
can’t convert orotic acid to UMP in the de novo pyrimidine synthesis pathway; due to a defect in either orotic acid phosphoribosyltransferase or orotidine 5’-phosphate decarboxylase
-Autosomal recessive
Adenosine Deaminase Deficinecy
Results in SCID (severe combined immunodeficiency disease)
can’t convert adenosine–>inosine in the purine salvage pathway, so get excess ATP and dATP, and thus feedback inhibition of ribonucleotide reductase (which imbalances the nucleotide pool); so prevents DNA synthesis and thus decreases the lymphocyte count
Absence of HGPRT
Lesch-Nyhan syndrome
- HGPRT converts hypoxanthine to IMP and guanine to GMP; without it, have defective purine salvage. Get excess uric acid production and de novo purine synthesis (so increased PRPP amidotransferase activity)
- X-linked recessive
- Findings: retardation, self-mutilation (lip-biting), aggression, hyperuricemia, gout, choreoathetosis
- Trtmnt: allopurinol (can’t treat CNS symptoms)
Allopurinol mechanism
inhibits xanthine oxidase (converts xanthine –> uric acid)
Origin of Replication
sequence of genome where DNA replication begins; single in prokaryotes, multiple in eukaryotes
Helicase
unwinds DNA template at replication fork
SSBPs (single-stranded binding proteins)
prevent strands from reannealing (stabilize unwound DNA)
Fluoroquinolones mechanism?
inhibit DNA gyrase (prokaryotic topoisomerase II)
Etoposide mechanism?
Inhibits human tropoisomerase (anti-cancer drug)
DNA topoisomerases
create a nick in the helix to relieve supercoils created during replication
DNA polymerase III
- Prokaryotic only
- Elongates leading strand by adding deoxynucleotides to the 3’ end.
- Elongates lagging strand until it reaches the primer of the preceding fragment
- 3’–>5’ exonuclease activity “proofreads” each added nucleotide.
- SO: 5’–>3’ synthesis; 3’–>5’ proofreading exonuclease
DNA polymerase I
Prokaryotic only
- Degrades RNA primer and fills in the gap with DNA (excision repair)
- SO:excises RNA primer with 5’–>3’ exonuclease
Telomerase
adds DNA to 3’ ends of chromosomes to avoid loss of genetic material with each duplication
anti-topoisomerase antibody
anti-SCL70 - in diffuse scleroderma
Nucleotide Excision Repair
- repair for small areas of damage
- mutated in xeroderma pigmentosum (can’t repair thymine dimers after UV light exposure)
- thymine dimers from UV light are usually repaired by NER
Base Excision Repair
-repair 1 damaged base
Mismatch Repair
unmethylated, newly synthesized string is recognized, mismatched nucleotides removed, and gap is filled and reasealed
-mutated in HNPCC (hereditary nonpolyposis colorectal cancer)
Nonhomologous end joining (type of double strand repair)
- mutated in ataxia telangiectasia
- brings together 2 ends of DNA fragments
- most abundant type of RNA?
- longest type?
- smallest type?
“rampant, massive, tiny”
rRNA = most abundant
mRNA = longest
tRNA = smallest
mRNA stop codons
- UGA (u go away)
- UAA (u are away)
- UAG (u are gone)
Promoter
site where RNA polymerase and other transciption factors bind to DNA
-located 25 (TATA or Hogness box) or 70 (CAAT box) bases upstream from their genes
Enhancers and Silencers
Enhancers = stretch of DNA that binds transcription factors
Silencers = where negative regulators (repressors) bind
*Both can be located anywhere upstream, downstream, or even within transcribed gene
Eukaryotic RNA Polymerases I, II, III
RNA pol I: makes rRNA
RNA pol II: makes mRNA
RNA pol III: makes tRNA
Prokaryotic RNA polymerase
only 1 RNA polymerase –> makes all 3 kinds of RNA
Rifampin inhibits?
inhibits prokaryotic RNA polymerase
Where are rRNA, mRNA, tRNA synthesized?
rRNA –> synthesized in nucleolus
mRNA and tRNA –> synthesized in nucleoplasm
After transcription, processing of the pre-mRNA in the nucleus:
1) Capping on 5’-end
2) Polyadenylation on 3’ end (poly-A tail)
3) splicing out of introns by the spliceosome (so, introns stay in nucleus, exons leave nucleus, form mRNA)
antibodies to spliceosomal snRNPs?
Lupus pts
Effect of glucose on the lac operon?
in presence of glucose: glucose inhibits cAMP, so get decreased cAMP –> decreased CAP (activator protei) –> inhibition of lac operon
So:
-if have glucose –> lac operon is off
-if not lactose –> lac operon is off
-if no glucose, but have lactose –> lac operon is ON!
Aminoacyl-tRNA synthetase: what does it do and where does it act?
works at the 3’-OH-end of the tRNA; charges the amino acid onto the tRNA molecule
-uses ATP
Tetracyclines mechanism
Tetracyclines bind 30S subunit, preventing attachment of aminoacyl-tRNA
Steps of Elongation in protein synthesis:
1) aminoacyl-tRNA binds A site
2) ribosomal rRNA (“ribozyme” = peptidyl transferase) catalyzes peptide bond formation; transfers growing polypeptide to amino acid in A site
3) Ribosome advance 3 nucleotides toward 3’ end of RNA, moving peptidyl RNA to P site (translocation)
APE:
A site: incoming Aminoacyl-tRNA
P site: accommodates growing Peptide
E site: holds Empty tRNA as it Exits
Aminoglycosides mechansim:
bind 30S on prokaryotic ribosome, and inhibit formation of the initiation complex and cause misreading of mRNA
Chloramphenicol mechanism
inhibits 50S peptidyltransferase
Macrolides mechanism
act on 50S subunit and block translocation (step 3 of elongation factor)
Clindamycin and Chloramphenicol mechanism
act at 50S; block peptide bond formation
Regulation of cell cycle by:
- Cyclic-dependent kinases
- Cyclins
- Cylcin-CDK complexes
- Rb and p53 (tumor suppressors)
- CDKs = cyclin-dependent kinases: constitutive and inactive; expressed constantly, but inactive unless activated
- Cyclins = activate CDKs
- Cyclin-CDK complexes: must be both activated and inactivated for cell cycle to progress
- Rb and p53: inhibit G1–>S progression; p53 also inhibits G2–>Mitosis
Which cell types are “permanent”, remaining in G0, regenerating from stem cells?
neurons, skeletal and cardiac muscles, RBCs
Which cell types are stable/quiescent –> enter G1 from G0 when stimulated?
hepatocytes, lymphocytes
Which cell types are labile –> never go to G0, divide rapidly with a short G1?
bone marrow, gut epithelium, skin, hair follicles (this type are most susceptible to cancer drugs)
Nissl bodies
RER in neurons (in dendrites; not in axons) –> synthesize enzymes and peptide neurotransmitters
What types of cells are rich in RER?
mucus-secreting goblet cells of the small intestine and antibody-secreting plasma cells
What types of cells are rich in SER?
liver hepatocytes (for drug and poison detox) and steroid-hormone producing cells of the adrenal cortex
Which amino acids are modified by the golgi?
- Asparagine
- Serine
- Threonine
Failure to add mannose-6-phosphate to lysosome proteins results in what disease?
I-cell disease = Inclusion cell disease;
inherited lysosomal storage disease. Since not tagged by mannose-6-phosphate, enzymes are secreted outside the cell instead of to the lysosome.
-Features: coarse facial features, clouded corneas, restricted joint movement, high plasma levels of lysosomal enzymes; often fatal in childhood
Peroxisome function
catabolism (breakdown) of very long fatty acids and amino acids
Proteasome function
barrel-shaped; degrades damaged or unnecessary proteins tagged for destruction with ubiquitin
Dynein and Kinesin
microtubule proteins:
- dynein: retrogradeto microtubule (+ to -)
- kinesin: anterograde to microtubule (- to +)
Immune disease due to a defect in microtubule polymerization?
Chediak-Higashi syndrome: microtubule polymerization defect resulting in decreased fusion of phagolysosomes and lysosomes; get recurrent pyogenic infections, partial albinism, peripheral nueropathy
Drugs that act on microtubules
1) -Bendazoles (anti-helminthic)
2) Griseofulvin (anti-fungal)
3) Vincristine/Vinblastine (anti-cancer) - block polymerization of microtubules
4) Paclitaxel (anti-breast cancer) - stabilizes microtubules
5) Colchicine (anti-gout)
Kartagener’s syndrome: cause, presentation
- immotile cilia due to a dynein arm defect
- Presentation:
- infertility (male and female)
- bronchiectasis
- recurrent sinusitis (because can’t push bacteria/particles out)
- situs inversus
Cytoskeletal elements
- actin and myosin
- microtubule (for movement)
- intermediate filaments (for structure: vimentin, desmin, cytokeratin, lamins, GFAP, neurofilaments)
Contents of the plasma membrane
- 50% cholesterol
- 50% phospholipids (phosphatidylcholine, lecithin, phosphatidyl inositol)
- also: sphingolipids, glycolipids, proteins
Stains for intermediate filaments: What types of cells do these stains stain?
- Vimentin
- Desmin
- Cytokeratin
- GFAP (glial fibrilary acid proteins)
- Neurofilaments
- Vimentin–>Connective tissue (so use for sarcomas, some carcinomas)
- Desmin –> muscle (rhabdomyosarcoma, leiomyosarcoma)
- cytokeratin–> epithelial cells (carcinomas, some sarcomas)
- GFAP –> neuroglia
- Neurofilaments –> neurons (adrenal neuroblastoma,primitive neuroectoderm tumors)
Oubain mechanism
inhibits the Na/K-ATPase by binding to the K site
Cardiac glycosides (digoxin, digotoxin) mechanism:
inhibit Na/K-ATPase, leading to indirect inhibition of Na/Ca-exchange; resulting in increased intracellular Ca and thus increased cardiac contractility
What are the 4 types of collagen?
“Strong, Slippery, Bloody BM!”
Type I: (90%) = Strong –> bone, skin, tendon, dentin, fascia, cornea, late wound repair
Type II: Slippery –> Cartilage (including hyaline)
Type III: Bloody –> skin, blood vessels, uterus, fetal tissue, granulation tissue (early wound healing)
Type IV: BM –> basement membrane and basal lamina
Collagen synthesis steps:
–Within Fibroblasts–
1) Synthesis in RER: Preprocollagen: Gly-X-Y polypeptide (X and Y are proline or lysine)
2) Hydorxylation of proline and lysine in ER: requires Vitamin C
3) Glycosylation in ER: formation of procollagen
4) Exocytosis of procollagen into extracellular space
–outside fibroblasts–
5) Proteolytic processing: procollagen is cleaved to become tropocollagen
6) Cross-linking: Collagen fibrils are formed by cross-linking tropocollagen molecules
Osteogenesis imperfecta:
-what type of collagen is defective?
=”brittle bone disease”
- Autosomal dominant, abnormal type 1 collagen (type 2 is fatal in-utero)
- defect is in the glycosylation phase (step 3) of collagen synthesis; can’t form triple helix (procollagen) from the pro-alpha-chain
- Symptoms:
- multiple fractures (may be during birth; may look like child abuse)
- blue sclerae
- hearing loss
- dental problems due to lack of dentin
Blue Sclerae?
Osteogenesis imperfecta
Defect in Type III collagen?
Ehlers-Danlos syndrome (defect is ouside fibroblasts, can’t crosslink tropocollagen to make collagen fibrils)
- “bloody” collagen defect (can be other types, but type III is most common)
- hyperextensible skin
- tendency to bleed (easy brusing, berry aneurysms, organ rupture)
- hypermobile joints (joint dislocation)
Type IV collagen defect
Alport syndrome –> “can’t see, can’t pee, can’t hear”
- usually X-linked recessive
- progressive hereditary nephritis and deafness; may have ocular disturbances too.
Which two amino acids is elastin rich in?
glycine and proline
alpha-1-antitrypsin, elastase, elastin… relationship?
What if alpha-1-antitrypsin is deficient?
Elastin is broken down by elastase.
alpha-1-antitrypsin inhibits elastase, so inhibits elastin breakdown.
in alpha-1-antitrypsin deficiency: can’t inhibit elastase, so get excessive elastase activity and excessive elastin breakdown (can result in panacinal emphysema)
Blotting procedures: Southern, Northern, Western, Southwestern
“SNoW DRoP”
Southern Blot –> DNA sample; DNA probe
Northern Blot –> RNA sample; DNA probe
Western Blot –> Protein sample; antibody probe
Southwestern Blot –> identifies DNA-binding proteins, like transcription factors,using labeled oligonucleotide probes
sensitivity and specificity of ELISA (enzyme-linked immunosorbent assay)? how does it work/what does it test?
ELISA tests antigen-antibody reactivity; probe pt’s blood sample with either:
- test antigen –> to see if immune system recognizes it/if antibody is there
- test antibody –> to see if a certain antigen is there
- solution has a color reaction if positive
- sensitivity and specificity both close to 100%
- Ex of how it works:
1) put antigen to a virus in tube
2) add pt’s serum (so, if pt has antibodies to virus, antibodies will bind virus antigens); rinse tube to get rid of unbound antibodies
3) add anti-human Ig that is also connected to an enzyme; these anti-human antibodies will bind the antibody-antigen complexes
4) add a substrate that will cause a color change of the enzyme, it it’s bound - Voila!*
Variable expression
severity of phenotype varies from 1 person to another (ie neurofibromatosis type 1, tuberous sclerosis –> may have varying severity)
Incomplete penetrance
not all individuals with mutant genotype show mutant phenotype
Pleiotropy
1 gene has >1 effect on an individual’s phenotype (ie PKU–> lots of seemingly unrelated symptoms)
Imprinting
differences in phenotype depend on whether mutation is maternal or paternal origin; occurs due to DNA methylation (ie Prader-Willi and Angelman’s syndromes)
Loss of heterozygosity
if a patient inherits or develops a mutation in a tumor suppressor gene, the complementary all has to be deleted/mutated before cancer develops (Retinoblastoma)
Dominant Negative mutation
a heterozygote produces a non-functional altered protein that also prevents the normal gene product from functioning; exerts a dominant effect (ie nonfunctional factor may bind DNA, thus preventing functional factor from binding)
Linkage disequilibrium
tendency for certain alleles at 2 linked loci to occur together more often than expected by chance; measured in a popl
Lyonization
random X-inactivation in females
Mosaicism
cells in body differ in genetic makeup d/t postfertilization loss of genetic info during mitosis
*germ-line/gonadal mosaic - child has a disease not carried by parent’s somatic cells
Locus heterogeneity
mutations at different loci can produce same phenotype
heteroplasmy
presence of both normal and mutated mitochondrial DNA –> so, have variable expression in mitochondrial inherited disease
uniparental disomy
kid gets 2 copies of a chromosome from 1 parent, none from the other
Hardy-Weinberg equations and what does the law assume?
p^2 + 2pq + q^2 = 1 p + q = 1 p^2 = freq of homozygosity for p q^2 = freq of homozygosity for q 2pq = freq of heterozygosity (carrier freq)
if X-linked:
- males = q
- females = q^2
Law assumes:
- no mutation
- no selection
- random matig
- no migration
Prader-Willi vs Angelman’s syndrome
both due to inactivation or deletion of genes on chromosome 15
-due to imprinting (1 allele is inactive d/t methylation); may also be d/t uniparental disomy
P-W: maternal allele is inactivated; paternal allele should be active but’s deleted; mental retardation, hyperphagia, obesity, hypogonadism, hypotonia
Angelman’s: inactive paternal allele; maternal allele should be active but is deleted; “happy puppet” –> MR, seizures, ataxia, inappropriate laughter.
Mitochondrial myopathies
seen in all offspring of infected mother
- leber’s hereditary optic neuropathy (acute loss of central vision)
- myoclonic epilepsy
- mitochondrial encephalopathy
- “ragged red fibers” on micrsocopy
Locus heterogeneity
mutations at different loci can produce same phenotype
heteroplasmy
presence of both normal and mutated mitochondrial DNA –> so, have variable expression in mitochondrial inherited disease
uniparental disomy
kid gets 2 copies of a chromosome from 1 parent, none from the other
Hardy-Weinberg equations and what does the law assume?
p^2 + 2pq + q^2 = 1 p + q = 1 p^2 = freq of homozygosity for p q^2 = freq of homozygosity for q 2pq = freq of heterozygosity (carrier freq)
if X-linked:
- males = q
- females = q^2
Law assumes:
- no mutation
- no selection
- random matig
- no migration
Prader-Willi vs Angelman’s syndrome
both due to inactivation or deletion of genes on chromosome 15
-due to imprinting (1 allele is inactive d/t methylation); may also be d/t uniparental disomy
P-W: maternal allele is inactivated; paternal allele should be active but’s deleted; mental retardation, hyperphagia, obesity, hypogonadism, hypotonia
Angelman’s: inactive paternal allele; maternal allele should be active but is deleted; “happy puppet” –> MR, seizures, ataxia, inappropriate laughter.
Mitochondrial myopathies
seen in all offspring of infected mother
- leber’s hereditary optic neuropathy (acute loss of central vision)
- myoclonic epilepsy
- mitochondrial encephalopathy
- “ragged red fibers” on micrsocopy
cell signaling defect of fibroblast growth factor (FGF) Receptor 3
Achondroplasia
- dwarfism, short limbs (but normal head and trunk)
- assoc with advanced paternal age
- autosomal dominant
90% of cases are due to mutation in PKD1 (on chrom 16)
ADPKD (autosomal dominant polycystic kidney disease)
- autosomal dominant
- ALWAYS BILATERAL, massive enlargement of kidneys d/t multiple cysts
- flank pain, hematuria, hypertension, progressive renal failure
- assoc with polycystic liver disease, berry aneurysms, mitral valve prolapse
Mutations of APC gene on chromosome 5
Familial Adenomatous Polyposis
- autosomal dominant
- colon covered with adenomatous polyps after puberty
- progresses to colon cancer, so have to do colonectomy